Publications, Jul 2018

• Tikhonova IA, Huxley N, Snowsill T, Crathorne L, Varley-Campbell J, Napier M, Hoyle M. Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England. Pharmacoeconomics 2018 Jul;36(7):837-851.

Date: 31 July 2018